Pathogenesis of nigral cell death in Parkinson's disease.
about
Computational systems analysis of dopamine metabolismRiluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyVanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicityProtein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degenerationAcrolein-mediated conduction loss is partially restored by K⁺ channel blockersNitrated alpha-synuclein and microglial neuroregulatory activities.Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury.Cellular stress responses: cell survival and cell deathThe substantia nigra conveys target-dependent excitatory and inhibitory outputs from the basal ganglia to the thalamus.Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseasesDevelopment of allosteric modulators of GPCRs for treatment of CNS disordersIdentification of key pathways and transcription factors related to Parkinson disease in genome wide.Remote control of neuronal signaling.Protein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress.Edible bird's nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells.Solid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride.Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's DiseaseNeuronal cell death in neurodegenerative diseases: recurring themes around protein handling.Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cellsGlutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.Modifications of the iron-neuromelanin system in Parkinson's disease.Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.Emerging drugs for Parkinson's disease.Molecular imaging in hereditary forms of parkinsonism.Role of activity-dependent mechanisms in the control of dopaminergic neuron survival.Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's diseaseMicroglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics.Development and application of neural stem cells for treating various human neurological diseases in animal models.Impairment of Atg5-dependent autophagic flux promotes paraquat- and MPP⁺-induced apoptosis but not rotenone or 6-hydroxydopamine toxicityRegulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory responseGlutamate receptors as therapeutic targets for Parkinson's disease.Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration.The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's diseaseCompulsive use of dopamine replacement therapy: a model for stimulant drug addiction?Peripheral stimulation in treating Parkinson's disease: Is it a realistic idea or a romantic whimsicality?The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells.Interferon Gamma potentiates the injury caused by MPP(+) on SH-SY5Y cells, which is attenuated by the nitric oxide synthases inhibition.Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons.
P2860
Q21144295-66907B77-DC0F-4C60-B0FF-9536613EE849Q24655620-838D628A-04FF-42B3-905E-906BD2FFB6B5Q28388187-0E8C21FD-9AD4-4D36-AB92-ADC6797E7804Q28582417-82AD5AF1-955D-48E2-9CF7-3466D68B682DQ28829557-A569FEDC-5D2E-4AE5-86B3-5469217B0943Q33315262-70CDC1AD-7A1E-454F-B9E9-5D0DE7834513Q33323265-26262361-4D58-47FA-9933-AC2C0EB18583Q33563284-4A85FC85-F418-49F8-8A82-36F5D93642B9Q33674213-BC688FBA-CF13-4A9F-93D1-B92D816A502CQ33707910-D6E64C3E-73FF-46AD-BD3B-8F957FF5B19DQ34063565-38E83877-C100-473A-81F7-E4B7303B53B0Q34373958-49770D46-A43A-43EA-874D-C6AFA9F2B5D9Q34449994-39E380C7-0FEE-4A87-A676-F015658C7BC1Q34858531-EFB4EC42-D28D-4609-9B14-713B04928E24Q35164624-38C82921-4C0F-4CD4-8FEA-8264264771C9Q35325532-9B7BDADE-31F8-43E9-9953-B9FBE2AE6D31Q35794829-8F79F34C-40D7-48CD-9004-99DD36BEDA0AQ35829484-CB6ACC4C-4110-4912-AA1D-00AA336DC71FQ35886625-520376B8-DC4C-44FB-9121-8EA12EE7E8CEQ36102771-B0C16914-29BB-4DE9-9DBB-F99F55DE6359Q36275187-EFD41E09-B64B-46F3-924E-5B4B1892AF42Q36326552-5381485A-1FC1-4869-84FB-E5BCC554B003Q36370608-3DDD6E4A-B3D2-4A2A-A366-5332A83DEE96Q36446511-D7B369A5-CC3F-4023-BE3C-9935E40C38C3Q36580572-05E332C9-568C-4A25-ABD6-D29DA85C461BQ36771898-19F1D30C-659E-4088-8B7B-E05CD14C17FFQ36777897-12E46C2F-DCD9-4E5C-BCFA-5597DE278156Q36998952-35C35FF8-AFF3-471F-90CA-914B66B6FDFCQ37214469-48428674-3F77-42A1-ACC5-A589BF18BD15Q37217325-C9C07CB6-277F-4552-B12A-FD169E925B52Q37312661-A593AE78-FDC2-4503-BEC1-D1F804228E97Q37336951-A6FE7E12-CD07-4848-9252-3DE9CA484943Q37585401-59785BA4-0A54-460D-AD9D-2D1B0143ACBBQ37755118-E8A169FD-1D2D-444C-91D7-6C5521CF2934Q37845675-B2A98424-014F-4A32-819F-FA9987521A4AQ37906769-27BC0A87-E511-4C78-AB3B-BA2BA5CFE7F1Q38262517-8E846696-2064-45C8-924B-ADC4149690CEQ38713790-79E7E024-B3AD-4D87-9936-FF8AD8A79308Q38949649-46D6E26B-EB6D-4E58-97F4-E5D20B5CC520Q39101398-0EA1D4F3-B6B7-4EBA-A063-FD4780E63038
P2860
Pathogenesis of nigral cell death in Parkinson's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pathogenesis of nigral cell death in Parkinson's disease.
@ast
Pathogenesis of nigral cell death in Parkinson's disease.
@en
type
label
Pathogenesis of nigral cell death in Parkinson's disease.
@ast
Pathogenesis of nigral cell death in Parkinson's disease.
@en
prefLabel
Pathogenesis of nigral cell death in Parkinson's disease.
@ast
Pathogenesis of nigral cell death in Parkinson's disease.
@en
P1476
Pathogenesis of nigral cell death in Parkinson's disease.
@en
P356
10.1016/J.PARKRELDIS.2004.10.012
P478
11 Suppl 1
P577
2005-06-01T00:00:00Z